Literature DB >> 28470572

Tumor-Associated Fibroblasts and Microvessels Contribute to the Expression of Immunosuppressive Factor Indoleamine 2, 3-Dioxygenase in Human Esophageal Cancers.

Guanglin Cui1,2,3, Can Li4, Gang Xu4, Zhenglu Sun4, Li Zhu4, Zhengfen Li4, Wei Zheng4, Junling Li4, Aping Yuan4.   

Abstract

Recent studies have provided considerable evidence to support the hypothesis that tumor stroma plays a crucial role in the induction of immune tolerance to human cancers. Here, we investigated the contribution of reactive stromal tumor-associated fibroblasts (TAFs) and microvessels to the immunosuppressive factor indoleamine 2,3-dioxygenase (IDO) expression in the ESCC microenvironment. The immunohistochemical (IHC) analyses demonstrated a significant increased densities of TAFs and microvessels in the ESCC stroma, double IHCs showed that these increased TAFs and microvessels were with a high proliferation activity. Further IHC examinations revealed that increased expression of IDO were frequently observed in the stromal cells with TAF morphology and microvessels. Double immunofluorescence examinations confirmed the colocalization of IDO positive cells with SMA-alpha positive TAFs and CD34 positive endothelial cells in the ESCC stroma. Our current findings strongly suggest that the activated stromal TAFs and endothelial cells of microvessels contribute to the expression of IDO and then the orchestration of immunosuppressive microenvironment.

Entities:  

Keywords:  Endothelial cells; Fibroblasts; Immunosuppression; carcinoma; esophagus; Indoleamine 2,3-dioxygenase

Mesh:

Substances:

Year:  2017        PMID: 28470572     DOI: 10.1007/s12253-017-0244-0

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  38 in total

Review 1.  Indoleamine 2,3-dioxygenase in immune suppression and cancer.

Authors:  Alexander J Muller; George C Prendergast
Journal:  Curr Cancer Drug Targets       Date:  2007-02       Impact factor: 3.428

2.  [Study of indoleamine 2,3-dioxygenase expression in patients of esophageal squamous cell carcinoma].

Authors:  Kenichi Sakurai; Katsuhisa Enomoto; Sadao Amano; Tomo Kimura; Kiminobu Sugito; Kei Kimizuka; Taro Ikeda; Masahiko Shibata; Nanao Negishi
Journal:  Gan To Kagaku Ryoho       Date:  2004-10

3.  Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer.

Authors:  Guanglin Cui; Haili Qi; Mona D Gundersen; Hang Yang; Ingrid Christiansen; Sveinung W Sørbye; Rasmus Goll; Jon Florholmen
Journal:  Cancer Immunol Immunother       Date:  2014-10-17       Impact factor: 6.968

Review 4.  Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment.

Authors:  Diego O Croci; Mariano F Zacarías Fluck; María J Rico; Pablo Matar; Gabriel A Rabinovich; O Graciela Scharovsky
Journal:  Cancer Immunol Immunother       Date:  2007-06-15       Impact factor: 6.968

Review 5.  Indoleamine 2,3-dioxygenase and tumor-induced tolerance.

Authors:  David H Munn; Andrew L Mellor
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

6.  Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

Authors:  Gerald Brandacher; Alexander Perathoner; Ruth Ladurner; Stefan Schneeberger; Peter Obrist; Christiana Winkler; Ernst R Werner; Gabriele Werner-Felmayer; Helmut G Weiss; Georg Göbel; Raimund Margreiter; Alfred Königsrainer; Dietmar Fuchs; Albert Amberger
Journal:  Clin Cancer Res       Date:  2006-02-15       Impact factor: 12.531

Review 7.  Anti-cancer therapies targeting the tumor stroma.

Authors:  Valeska Hofmeister; David Schrama; Jürgen C Becker
Journal:  Cancer Immunol Immunother       Date:  2007-07-27       Impact factor: 6.968

8.  Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma.

Authors:  Ke Pan; Hui Wang; Min-shan Chen; Hua-kun Zhang; De-sheng Weng; Jun Zhou; Wei Huang; Jian-jun Li; Hai-feng Song; Jian-chuan Xia
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-26       Impact factor: 4.553

Review 9.  IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance.

Authors:  David H Munn; Andrew L Mellor
Journal:  Trends Immunol       Date:  2016-01-31       Impact factor: 16.687

10.  Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.

Authors:  Ge Zhang; Wan-Li Liu; Lin Zhang; Jun-Ye Wang; Miao-Huan Kuang; Peng Liu; Yue-Hao Lin; Shu-Qin Dai; Jun Du
Journal:  Clin Dev Immunol       Date:  2011-10-13
View more
  7 in total

1.  IL-33 in the tumor microenvironment is associated with the accumulation of FoxP3-positive regulatory T cells in human esophageal carcinomas.

Authors:  Guanglin Cui; Zhenfeng Li; Jingli Ren; Aping Yuan
Journal:  Virchows Arch       Date:  2019-05-06       Impact factor: 4.064

Review 2.  Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet.

Authors:  Steven Zhao; Ronal M Peralta; Natalia Avina-Ochoa; Greg M Delgoffe; Susan M Kaech
Journal:  Semin Immunol       Date:  2021-08-27       Impact factor: 10.671

Review 3.  The Role of Indoleamine 2, 3-Dioxygenase 1 in Regulating Tumor Microenvironment.

Authors:  Xinting Huang; Feng Zhang; Xiaobo Wang; Ke Liu
Journal:  Cancers (Basel)       Date:  2022-06-01       Impact factor: 6.575

4.  Cellular and clinicopathological features of the IL-33/ST2 axis in human esophageal squamous cell carcinomas.

Authors:  Guanglin Cui; Jingli Ren; Gang Xu; Zhenfeng Li; Wei Zheng; Aping Yuan
Journal:  Cancer Cell Int       Date:  2018-12-11       Impact factor: 5.722

Review 5.  IDO Expression in Cancer: Different Compartment, Different Functionality?

Authors:  Annabel Meireson; Michael Devos; Lieve Brochez
Journal:  Front Immunol       Date:  2020-09-24       Impact factor: 7.561

Review 6.  Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor.

Authors:  Xiaotian Song; Qianqian Si; Rui Qi; Weidan Liu; Miao Li; Mengyue Guo; Lin Wei; Zhiyan Yao
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

7.  The expression of RIPK3 is associated with cell turnover of gastric mucosa in the mouse and human stomach.

Authors:  Guanglin Cui; Yaobo Yuan; Yanan Wang; Zhenfeng Li
Journal:  J Mol Histol       Date:  2021-06-25       Impact factor: 2.611

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.